Grufity logo
Grufity logo

Latest SECTOR GAMMA AS Stock Portfolio

$460Million | No. of Holdings #40

SECTOR GAMMA AS Performance

2026 Q2+5.06%
YTD+3.76%
2025+14.39%

About SECTOR GAMMA AS and 13F Hedge Fund Stock Holdings

On 2026-08-12, the fund reported it's updated stock portfolio. In the 13F Holdings report, SECTOR GAMMA AS reported an equity portfolio of $461 Millions as of 30 Jun, 2026. <br><br> The top stock holdings of SECTOR GAMMA AS are BMY, MRK, MDT. The fund has invested 9.1% of it's portfolio in BRISTOL-MYERS SQUIBB CO and 6% of portfolio in MERCK & CO INC. <br><br> The fund managers got completely rid off UNITEDHEALTH GROUP INC (UNH), GILEAD SCIENCES INC (GILD) and LANTHEUS HLDGS INC (LNTH) stocks. They significantly reduced their stock positions in AMGEN INC (AMGN), BRUKER CORP (BRKR) and BIOGEN INC (BIIB). SECTOR GAMMA AS opened new stock positions in THERMO FISHER SCIENTIFIC INC (TMO), REGENERON PHARMACEUTICALS (REGN) and ASCENDIS PHARMA A/S. The fund showed a lot of confidence in some stocks as they added substantially to IQVIA HLDGS INC (IQV), DEXCOM INC (DXCM) and QIAGEN NV (QGEN).
SECTOR GAMMA AS Equity Portfolio Value
Last Reported on: 12 Aug, 2026
$460Million
  as of Aug 12, 2026

SECTOR GAMMA AS Annual Return Estimates Vs S&P 500

Our best estimate is that SECTOR GAMMA AS made a return of 5.06% in the last quarter. In trailing 12 months, it's portfolio return was 18.14%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
thermo fisher scientific inc16,837,700
regeneron pharmaceuticals9,839,460
ascendis pharma a/s5,682,470
boston scientific corp5,169,740
travere therapeutics inc4,544,800
cytokinetics inc3,833,550
intellia therapeutics inc3,133,200
New stocks bought by SECTOR GAMMA AS

Additions

Ticker% Inc.
iqvia hldgs inc93.75
dexcom inc81.96
qiagen nv77.15
abbott labs68.45
ge healthcare technologies i64.43
bio rad labs inc40.42
labcorp holdings inc36.81
ptc therapeutics inc33.33
Additions to existing portfolio by SECTOR GAMMA AS

Reductions

Ticker% Reduced
amgen inc-44.27
bruker corp-40.02
biogen inc-39.88
organon & co-27.98
cardinal health inc-25.88
merck & co inc-16.64
syndax pharmaceuticals inc-15.48
incyte corp-14.84
SECTOR GAMMA AS reduced stake in above stock

Sold off

Ticker$ Sold
denali therapeutics inc-3,124,030
lantheus hldgs inc-7,080,140
cogent biosciences inc-3,079,200
gilead sciences inc-7,421,030
bridgebio pharma inc-3,286,970
unitedhealth group inc-9,858,950
arrowhead pharmaceuticals in-1,881,000
ascendis pharma a/s-4,873,090
SECTOR GAMMA AS got rid off the above stocks

Sector Distribution

SECTOR GAMMA AS has about 89.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
  • Basic Materials
Sector%
Healthcare89.9
Others8.1
Basic Materials1.9

Market Cap. Distribution

SECTOR GAMMA AS has about 68.2% of it's portfolio invested in the large-cap and mega-cap stocks.

  • LARGE-CAP
  • MID-CAP
  • MEGA-CAP
  • UNALLOCATED
  • SMALL-CAP
  • MICRO-CAP
Category%
LARGE-CAP56.4
MID-CAP12.9
MEGA-CAP11.8
UNALLOCATED8.1
SMALL-CAP7.1
MICRO-CAP3.7

Stocks belong to which Index?

About 75.6% of the stocks held by SECTOR GAMMA AS either belong to S&P 500 or RUSSELL 2000 index.

  • S&P 500
  • Others
  • RUSSELL 2000
Index%
S&P 50066.6
Others24.4
RUSSELL 20009
Top 5 Winners (%)%
OGN
organon & co
108.4 %
CNC
centene corp del
96.1 %
BRKR
bruker corp
53.3 %
CVS
cvs health corp
40.1 %
KURA
kura oncology inc
33.8 %
Top 5 Winners ($)$
CNC
centene corp del
5.1 M
BRKR
bruker corp
4.9 M
CVS
cvs health corp
4.6 M
ANTX
elevance health inc formerly
4.2 M
INCY
incyte corp
3.6 M
Top 5 Losers (%)%
TNDM
tandem diabetes care inc
-21.3 %
PFE
pfizer inc
-13.7 %
ARDX
ardelyx inc
-13.3 %
ABT
abbott labs
-9.5 %
MDT
medtronic plc
-8.8 %
Top 5 Losers ($)$
PFE
pfizer inc
-4.2 M
MDT
medtronic plc
-2.7 M
BMY
bristol-myers squibb co
-2.4 M
ABT
abbott labs
-1.4 M
ge healthcare technologies i
-1.2 M

SECTOR GAMMA AS Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of SECTOR GAMMA AS

SECTOR GAMMA AS has 40 stocks in it's portfolio. About 48.4% of the portfolio is in top 10 stocks. PFE proved to be the most loss making stock for the portfolio. CNC was the most profitable stock for SECTOR GAMMA AS last quarter.

$460.97MTotal Value
49.00Positions
12 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of SECTOR GAMMA AS, last reported on 12 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
ASND
Ascendis Pharma A/S

Ascendis Pharma A/S

ASND
SECTOR GAMMA AS's holding in Ascendis Pharma A/S over time
0%0.00
$0.00
0%
decreased 100 percentsold off